L. Pagano Et Al. , "Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey," Blood , vol.140, no.26, pp.2773-2787, 2022
Pagano, L. Et Al. 2022. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. Blood , vol.140, no.26 , 2773-2787.
Pagano, L., Salmanton-García, J., Marchesi, F., Blennow, O., Gomes da Silva, M., Glenthøj, A., ... van Doesum, J.(2022). Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. Blood , vol.140, no.26, 2773-2787.
Pagano, Livio Et Al. "Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey," Blood , vol.140, no.26, 2773-2787, 2022
Pagano, Livio Et Al. "Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey." Blood , vol.140, no.26, pp.2773-2787, 2022
Pagano, L. Et Al. (2022) . "Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey." Blood , vol.140, no.26, pp.2773-2787.
@article{article, author={Livio Pagano Et Al. }, title={Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey}, journal={Blood}, year=2022, pages={2773-2787} }